<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Chronic cough — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Chronic cough</h1>
        <div class="sub">Adults with cough &gt;8 weeks: identify red flags, do baseline tests (CXR + spirometry ± FeNO), treat common “treatable traits” (don’t empirically over-treat), and refer/route appropriately (incl. lung cancer caution).</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑10</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
              <h3>Evidence summary (triangulated)</h3>

              <div class="callout ok">
                <strong>Key design points</strong>
                <ul>
                  <li>BTS clinical statement (Thorax 2023) recommends a <strong>systematic primary‑care assessment</strong> for cough &gt;8 weeks: history/exam including upper airway + cardio‑resp, and <strong>baseline tests</strong> of <strong>CXR</strong>, <strong>spirometry</strong> and (where available) <strong>FeNO</strong> plus <strong>FBC</strong>. Consider sputum microbiology (incl. AFB) if productive/high-risk.</li>
                  <li>Before “labelling” the cough, BTS emphasises identifying and treating <strong>aggravants</strong> (ACE inhibitor, smoking) and addressing <strong>treatable traits</strong> using <strong>objective evidence or symptoms</strong>; avoid broad empirical therapy (e.g. routine PPI without reflux symptoms).</li>
                  <li>Red flags should trigger urgent imaging/referral. NICE NG12 specifically supports <strong>urgent CXR (within 2 weeks)</strong> for people aged ≥40 with <strong>unexplained cough</strong> when combined with other unexplained symptoms, or with a smoking/asbestos history plus at least one listed symptom.</li>
                </ul>
              </div>

              <div class="callout warn">
                <strong>Local-process sensitivity</strong>
                <ul>
                  <li>Exact routes differ for: <strong>urgent CXR</strong>, access to <strong>spirometry/FeNO</strong>, and the threshold for <strong>suspected lung cancer pathway</strong> referral when the CXR is normal but symptoms persist.</li>
                  <li>This page provides a safe decision structure + a local‑agreement checklist to localise for D&amp;G.</li>
                </ul>
              </div>

              <h4>Comparator sources used for the draft</h4>
              <ul>
                <li>British Thoracic Society Clinical Statement (Thorax 2023): approach to chronic cough in adults (primary‑care assessment, red flags, treatable traits).</li>
                <li>NICE NG12 (Suspected cancer: recognition and referral): lung/pleural cancer recommendations (urgent CXR criteria; suspected cancer pathway referral triggered by CXR findings and other criteria).</li>
              </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">
            <div id="draftText" class="section">
              <h3>Chronic cough (&gt;8 weeks) — adults (primary care)</h3>

              <h4>Scope / definition</h4>
              <ul>
                <li><strong>Chronic cough</strong> = cough lasting <strong>&gt;8 weeks</strong>.</li>
                <li>Separate pathway needed for children, pregnancy, and significant immunocompromise (lower threshold for same‑day assessment).</li>
              </ul>

              <h4>Immediate red flags (999 / ED now)</h4>
              <ul>
                <li><strong>Severe breathlessness</strong>, hypoxia, respiratory distress, or exhaustion.</li>
                <li><strong>Haemoptysis with instability</strong> or large-volume ongoing bleeding.</li>
                <li><strong>Chest pain with collapse</strong>, or concern for PE with instability.</li>
                <li><strong>Sepsis</strong> features or markedly unwell patient.</li>
              </ul>

              <h4>Urgent / suspected cancer pathway red flags (act urgently; same day or 2WW/urgent CXR per local process)</h4>
              <ul>
                <li><strong>Haemoptysis</strong> (see haemoptysis page).</li>
                <li><strong>Systemic features</strong>: unexplained weight loss, fever, night sweats, anorexia, marked fatigue.</li>
                <li><strong>Persistent hoarseness</strong> or concerning dysphagia symptoms.</li>
                <li><strong>Recurrent/persistent chest infections</strong> or persistent focal chest signs.</li>
                <li><strong>Age ≥40</strong> with risk factors (current/ex‑smoker or asbestos exposure) and unexplained cough (especially if with other NG12 symptoms).</li>
              </ul>

              <h4>Step 1 — core history / examination</h4>
              <ul>
                <li><strong>Character/timing:</strong> dry vs productive; triggers; nocturnal; post‑viral; episodic vs daily; duration.</li>
                <li><strong>Associated symptoms:</strong> breathlessness, wheeze, chest pain, heartburn/regurgitation, post‑nasal drip/rhinitis, voice change, fever, weight loss.</li>
                <li><strong>Exposures:</strong> smoking/vaping; occupational (incl. asbestos); household mould; travel/TB exposure.</li>
                <li><strong>Medication:</strong> <strong>ACE inhibitor</strong> (and when started); other drugs that may irritate airways.</li>
                <li><strong>Examination:</strong> upper airway (nose/throat), chest, cardiovascular system; consider lymph nodes.</li>
              </ul>

              <h4>Step 2 — baseline tests in primary care (do early)</h4>
              <ul>
                <li><strong>CXR</strong> (particularly if unexplained, persistent symptoms, or any red flags).</li>
                <li><strong>Spirometry</strong> (with bronchodilator reversibility if indicated).</li>
                <li><strong>FeNO</strong> if available (helps identify eosinophilic airway inflammation / likely steroid response).</li>
                <li><strong>FBC</strong> (consider eosinophils; anaemia/infection clues).</li>
                <li><strong>Sputum culture</strong> if productive; consider TB testing/AFB where risk features (local process).</li>
              </ul>

              <h4>Step 3 — remove aggravants</h4>
              <ul>
                <li><strong>ACE inhibitor:</strong> stop/switch if possible (can take weeks to resolve).</li>
                <li><strong>Smoking/vaping:</strong> offer cessation support; advise it is a common driver of chronic cough.</li>
              </ul>

              <h4>Step 4 — treat “treatable traits” (avoid blind empirical treatment)</h4>
              <ul>
                <li><strong>Airway disease</strong> (asthma/COPD/airflow limitation): optimise inhaled therapy per local guidance.</li>
                <li><strong>Possible eosinophilic airway disease</strong>: consider a <strong>1‑month inhaled corticosteroid (ICS) trial</strong> if supportive evidence (e.g. raised FeNO and/or eosinophils; or clear asthma symptoms/wheeze).</li>
                <li><strong>Rhinosinusitis / upper airway symptoms</strong>: trial <strong>intranasal steroid</strong> and saline irrigation/douching if symptoms/signs consistent.</li>
                <li><strong>Reflux</strong>: trial <strong>PPI only if reflux symptoms</strong> (e.g. heartburn/regurgitation); focus on lifestyle measures where appropriate.</li>
                <li><strong>Anxiety / cough hypersensitivity context</strong>: explain cough hypersensitivity; consider non‑pharmacological strategies and address contributing anxiety/depression where present.</li>
              </ul>

              <h4>When to refer / where to send</h4>
              <ul>
                <li><strong>Suspected lung cancer pathway referral / urgent imaging</strong> if:
                  <ul>
                    <li>Red‑flag features (above), or</li>
                    <li><strong>Abnormal CXR</strong> suspicious for malignancy, or</li>
                    <li>NICE NG12 criteria for <strong>urgent CXR</strong> are met (and act on the result promptly).</li>
                  </ul>
                </li>
                <li><strong>Routine respiratory referral</strong> if:
                  <ul>
                    <li>Cough persists despite: removal of aggravants + baseline tests + targeted treatment of identified traits, or</li>
                    <li>Recurrent productive cough / bronchiectasis suspicion, abnormal spirometry needing specialist input, or</li>
                    <li>Diagnostic uncertainty.</li>
                  </ul>
                </li>
                <li><strong>ENT consideration</strong> if prominent throat symptoms/voice change suggest laryngeal pathology and CXR/spirometry are reassuring (local route).</li>
              </ul>

              <h4>Safety‑netting</h4>
              <ul>
                <li>Seek urgent help if: new haemoptysis, worsening breathlessness, chest pain, fever/systemic decline, weight loss, or any red flag develops.</li>
                <li>Ensure a results-follow-up plan for CXR/spirometry/FeNO/bloods, with a clear review date.</li>
              </ul>

              <h4>Local agreement needed (D&amp;G)</h4>
              <ul>
                <li><label><input type="checkbox" /> What is the local route/timescale for <strong>urgent CXR (within 2 weeks)</strong> for suspected lung cancer features?</label></li>
                <li><label><input type="checkbox" /> What access exists in primary care to <strong>spirometry</strong> and <strong>FeNO</strong> (and what is the default pathway if unavailable)?</label></li>
                <li><label><input type="checkbox" /> If CXR is normal but cough persists with cancer concern: local expectation for <strong>direct-access CT chest</strong> vs respiratory clinic vs 2WW referral.</label></li>
                <li><label><input type="checkbox" /> TB testing route (who orders, which tests) for chronic cough + TB risk features.</label></li>
              </ul>

              <div class="callout warn">
                <strong>Reminder</strong>
                <div class="small">Chronic cough is common, but don’t normalise it: do baseline tests early and keep a low threshold to escalate if red flags or abnormal CXR.</div>
              </div>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References</h3>
              <ul>
                <li>Parker SM, Smith JA, Birring SS, et al. <em>British Thoracic Society Clinical Statement on chronic cough in adults</em>. Thorax. 2023;78(Suppl 6):s3–s19. doi:10.1136/thorax-2023-220592. Accessed 2026‑02‑10. https://pubmed.ncbi.nlm.nih.gov/38088193/</li>
                <li>NICE. <em>Suspected cancer: recognition and referral (NG12)</em>. Recommendations organised by site of cancer (lung and pleural cancers). Updated/amended (see NICE page). Accessed 2026‑02‑10. https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer</li>
              </ul>
            </div>
          </div>

        </div>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
